JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
PRA Group
PRAA
$776M
| $1.36M | ﹤0.01% |
37,513
+1,934
| +5% | +$76.7K |
|
|
TIPD
3677
DELISTED
Direxion Daily TIPS Bear 2X Shares
TIPD
| $1.36M | ﹤0.01% |
+50,000
| New | +$1.29M |
|
3678
PUT
Trex
TREX
$5.06B
| $1.36M | ﹤0.01% |
+25,000
| New | +$1.51M |
|
|
DNAB
3679
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $1.36M | ﹤0.01% |
+139,540
| New | +$1.36M |
|
3680
Vera Therapeutics
VERA
$2.28B
| $1.35M | ﹤0.01% |
98,936
-50,665
| -34% | -$884K |
|
|
YI
3681
111 Inc
YI
$32.3M
| $1.35M | ﹤0.01% |
65,394
-3,912
| -6% | -$78.1K |
|
|
RETA
3682
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.35M | ﹤0.01% |
44,310
+16,148
| +57% | +$482K |
|
3683
monday.com
MNDY
$3.7B
| $1.34M | ﹤0.01% |
13,026
-59,798
| -82% | -$7.26M |
|
3684
Zillow
ZG
$7.91B
| $1.34M | ﹤0.01% |
42,205
+24,572
| +139% | +$970K |
|
|
DNB
3685
DELISTED
Dun & Bradstreet
DNB
| $1.34M | ﹤0.01% |
89,194
+46,496
| +109% | +$749K |
|
3686
Veracyte
VCYT
$3.32B
| $1.34M | ﹤0.01% |
67,372
+12,052
| +22% | +$243K |
|
|
ADAM
3687
Adamas Trust
ADAM
$910M
| $1.34M | ﹤0.01% |
121,057
-156,356
| -56% | -$1.92M |
|
3688
InMode
INMD
$872M
| $1.33M | ﹤0.01% |
59,346
-19,987
| -25% | -$525K |
|
3689
CALL
Illumina
ILMN
$28.8B
| $1.33M | ﹤0.01% |
+7,402
| New | +$1.89M |
|
|
RSX
3690
DELISTED
VanEck Russia ETF
RSX
| $1.32M | ﹤0.01% |
234,535
| – | – |
|
|
LOVE
3691
PUT
LoveSac
LOVE
$253M
| $1.32M | ﹤0.01% |
+48,100
| New | +$1.87M |
|
3692
Quanex
NX
$962M
| $1.32M | ﹤0.01% |
58,135
-295,842
| -84% | -$6.17M |
|
3693
Joby Aviation
JOBY
$7.83B
| $1.31M | ﹤0.01% |
267,755
-58,130
| -18% | -$306K |
|
3694
KRONOS Worldwide
KRO
$975M
| $1.31M | ﹤0.01% |
71,177
-33,193
| -32% | -$567K |
|
3695
Magnachip Semiconductor
MX
$139M
| $1.31M | ﹤0.01% |
90,206
+74,668
| +481% | +$1.28M |
|
|
MVLA
3696
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $1.31M | ﹤0.01% |
133,401
-766,599
| -85% | -$7.52M |
|
|
CBL
3697
CBL Properties
CBL
$1.8B
| $1.3M | ﹤0.01% |
55,507
+33,656
| +154% | +$940K |
|
3698
Ryan Specialty Holdings
RYAN
$10.7B
| $1.3M | ﹤0.01% |
33,222
+4,524
| +16% | +$171K |
|
|
EXE
3699
CALL
Expand Energy Corp
EXE
$21.9B
| $1.3M | ﹤0.01% |
+16,000
| New | +$1.45M |
|
3700
PDF Solutions
PDFS
$2.15B
| $1.3M | ﹤0.01% |
60,287
+1,618
| +3% | +$37.4K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.